Edwards Lifesciences Corporation Noncontrolling Interest, Period Increase (Decrease)
Edwards Lifesciences Corporation (EW) reported Noncontrolling Interest, Period Increase (Decrease) of $112.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:MinorityInterestPeriodIncreaseDecrease · last filed 2026-08-04
- Edwards Lifesciences Corporation noncontrolling interest, period increase (decrease) for the quarter ending 2026-06-30 was $112.40M.
- Edwards Lifesciences Corporation noncontrolling interest, period increase (decrease) for the quarter ending 2025-12-31 was $0.00.
- Edwards Lifesciences Corporation noncontrolling interest, period increase (decrease) for the quarter ending 2025-09-30 was -$173.30M.
- Edwards Lifesciences Corporation noncontrolling interest, period increase (decrease) for the quarter ending 2024-12-31 was $0.00.
- Edwards Lifesciences Corporation noncontrolling interest, period increase (decrease) for fiscal 2025 was -$173.30M.
- Edwards Lifesciences Corporation noncontrolling interest, period increase (decrease) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Edwards Lifesciences Corporation noncontrolling interest, period increase (decrease) for fiscal 2023 was $72.40M.
| Period end | Noncontrolling Interest, Period Increase (Decrease) 3 month | Noncontrolling Interest, Period Increase (Decrease) 6 month | Noncontrolling Interest, Period Increase (Decrease) 9 month | Noncontrolling Interest, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $112.40M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$173.30M derived: sum of 2 quarters · filed 2026-02-25 | -$173.30M 10-K · filed 2026-02-25 | |
| 2025-09-30 | -$173.30M 10-Q · filed 2025-11-05 | -$173.30M 10-Q · filed 2025-11-05 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2023-12-31 | $72.40M 10-K · filed 2025-02-28 | |||
| 2023-06-30 | -$11.60M 10-Q · filed 2024-11-06 | $72.40M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $84.00M 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |